Maria L.H. Vlaming - Concepedia

Author

Maria L.H. Vlaming

Also Known As

M. L. H. Vlaming, M. L.H. Vlaming, M. Vlaming, M.L.H. Vlaming, Maria L H Vlaming, Maria L. H. Vlaming, Maria L. Vlaming, Maria L.H. Vlaming, Maria LH Vlaming, Maria LH. Vlaming

Publications

1.8K

Citations

H-Index

Concepts

All Affiliations

The Netherlands Cancer Institute Slotervaartziekenhuis Amsterdam UMC Location University of Amsterdam Istanbul University Netherlands Organisation for Applied Scientific Research

About

Maria L.H. Vlaming is an author at The Netherlands Cancer Institute specializing in medicine, pharmacology, and engineering.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	372
2	Engineering	3	3	74
3	Biochemistry	3	3	194
4	Natural Sciences	2	2	177
5	Health Sciences	1	1	29

Maria L.H. Vlaming

Publications

1.5K

Citations

H-Index

Page 1

	Year	Citations
Carcinogen and Anticancer Drug Transport by Mrp2 in Vivo: Studies Using Mrp2 (Abcc2) Knockout Mice Maria L.H. Vlaming, Karin Mohrmann, Els Wagenaar, Journal of Pharmacology and Experimental Therapeutics	2006	155
Differential, strain-specific cellular and subcellular distribution of multidrug transporters in murine choroid plexus and blood–brain barrier A. Soontornmalai, Maria L.H. Vlaming, Jean‐Marc Fritschy Neuroscience BiochemistryBlood–brain BarrierMedicineMembrane TransportPhysiology	2005	139
Multidrug Resistance Proteins 2 and 3 Provide Alternative Routes for Hepatic Excretion of Morphine-Glucuronides Koen van de Wetering, Noam Zelcer, Annemieke Kuil, Molecular Pharmacology	2007	108
P-glycoprotein (P-gp/Abcb1), Abcc2, and Abcc3 Determine the Pharmacokinetics of Etoposide Jurjen S. Lagas, Fan Lin, Els Wagenaar, Clinical Cancer Research	2009	94
Hepatic Transport Mechanisms of Cholyl-l-Lysyl-Fluorescein Dirk R. de Waart, Stéphanie Häusler, Maria L.H. Vlaming, Journal of Pharmacology and Experimental Therapeutics	2010	90
Multidrug Resistance Protein 2 Is an Important Determinant of Paclitaxel Pharmacokinetics Jurjen S. Lagas, Maria L.H. Vlaming, Olaf van Tellingen, Clinical Cancer Research	2006	90
Functionally Overlapping Roles of Abcg2 (Bcrp1) and Abcc2 (Mrp2) in the Elimination of Methotrexate and Its Main Toxic Metabolite 7-Hydroxymethotrexate <i>In vivo</i> Maria L.H. Vlaming, Zeliha Pala, Anita van Esch, Clinical Cancer Research	2009	84
Predicting carrier-mediated hepatic disposition of rosuvastatin in man by scaling from individual transfected cell-lines in vitro using absolute transporter protein quantification and PBPK modeling Sieto Bosgra, Evita van de Steeg, Maria L.H. Vlaming, European Journal of Pharmaceutical Sciences Translational MedicineHepatologyCarrier-mediated Hepatic DispositionLiver PhysiologyBioanalysis	2014	71
Comparison of 10 Control hPSC Lines for Drug Screening in an Engineered Heart Tissue Format Ingra Mannhardt, Umber Saleem, Diogo Mosqueira, Stem Cell Reports	2020	70
Blinded, Multicenter Evaluation of Drug-induced Changes in Contractility Using Human-induced Pluripotent Stem Cell-derived Cardiomyocytes Umber Saleem, Berend J. van Meer, Puspita Anggraini Katili, Toxicological Sciences	2020	68

Page 1